Evaluation of Cumulative Meta-analysis of Rare Events as a Tool for Clinical Trials Safety Monitoring

This meta-analysis evaluates the use of cumulative meta-analysis of rare events as a tool for safety monitoring of clinical trials using the example of coronary bioresorbable vascular scaffold–associated thrombosis.

Detalles Bibliográficos
Autores principales: Siontis, George C. M., Nikolakopoulou, Adriani, Efthimiou, Orestis, Räber, Lorenz, Windecker, Stephan, Jüni, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489838/
https://www.ncbi.nlm.nih.gov/pubmed/32886118
http://dx.doi.org/10.1001/jamanetworkopen.2020.15031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489838/
https://www.ncbi.nlm.nih.gov/pubmed/32886118
http://dx.doi.org/10.1001/jamanetworkopen.2020.15031

Ejemplares similares